Siro Clinpharm Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 0.61 M
as on 24-10-2024
- Company Age 24 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.37 Cr
as on 24-10-2024
- Satisfied Charges ₹ 119.93 Cr
as on 24-10-2024
- Revenue 33.99%
(FY 2023)
- Profit 467.04%
(FY 2023)
- Ebitda -76.90%
(FY 2023)
- Net Worth 245.67%
(FY 2023)
- Total Assets 140.24%
(FY 2023)
About Siro Clinpharm
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 0.61 M.
The company currently has active open charges totaling ₹2.37 Cr. The company has closed loans amounting to ₹119.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gautam Daftary, Akshay Daftary, and Karan Daftary serve as directors at the Company.
- CIN/LLPIN
U24230MH2000PTC125061
- Company No.
125061
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Siro Clinpharm Private Limited offer?
Siro Clinpharm Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Risk Management Services, Data Entry & Data Processing Service, Data Management, Language Translation Service, Copywriting & Content Development, Content Writing Service, Data Processing, Examination Data Processing.
Who are the key members and board of directors at Siro Clinpharm?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karan Daftary  | Whole-Time Director | 12-Sep-2018 | Current |
| Gautam Daftary | Director | 21-Mar-2000 | Current |
| Akshay Daftary | Director | 12-Feb-2018 | Current |
Financial Performance and Corporate Structure Insights of Siro Clinpharm.
Siro Clinpharm Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.99% increase. The company also saw a substantial improvement in profitability, with a 467.04% increase in profit. The company's net worth Soared by an impressive increase of 245.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siro Clinpharm?
In 2023, Siro Clinpharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Palettier Retail Private LimitedActive 3 years 4 months
Gautam Daftary and Akshay Daftary are mutual person
- Aksitech Life Sciences Private LimitedActive 30 years 6 months
Gautam Daftary and Akshay Daftary are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Mar 2024 | ₹1.37 Cr | Open |
Others Creation Date: 24 Nov 2021 | ₹1.00 Cr | Open |
Others Creation Date: 12 Mar 2019 | ₹4.50 Cr | Satisfied |
How Many Employees Work at Siro Clinpharm?
Siro Clinpharm has a workforce of 258 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siro Clinpharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siro Clinpharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
